Page last updated: 2024-08-23

paclitaxel and Digestive System Neoplasms

paclitaxel has been researched along with Digestive System Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, JS; Jang, SI; Jeong, S; Kim, YT; Lee, DH; Lee, DK; Lee, KT; Lee, SH; Yu, JS1
Chi, YH; Du, F; Jiang, WC; Song, Y; Sun, YK; Wang, JW; Yang, L; Zhou, AP1
Hamaguchi, T; Ikeda, M; Kato, K; Matsumura, Y; Morizane, C; Muro, K; Nakahama, H; Okusaka, T; Shimada, Y; Shirao, K; Ueno, H; Yamada, Y; Yasui, H1
Akerman, P; Cioffi, W; Gaissert, H; Hesketh, PJ; Joseph, P; King, T; Safran, H; Wanebo, H1
Brátová, M; Kohout, P; Králícková, P; Melichar, B; Solichová, D; Zadák, Z1

Trials

2 trial(s) available for paclitaxel and Digestive System Neoplasms

ArticleYear
Efficacy of a paclitaxel-eluting biliary metal stent with sodium caprate in malignant biliary obstruction: a prospective randomized comparative study.
    Endoscopy, 2019, Volume: 51, Issue:9

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents, Phytogenic; Cholestasis; Decanoic Acids; Digestive System Neoplasms; Drug-Eluting Stents; Humans; Middle Aged; Paclitaxel; Prospective Studies

2019
Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.
    Seminars in radiation oncology, 1999, Volume: 9, Issue:2 Suppl 1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Digestive System Neoplasms; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Stomach Neoplasms

1999

Other Studies

3 other study(ies) available for paclitaxel and Digestive System Neoplasms

ArticleYear
[Neuroendocrine tumors: analysis of 252 cases].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2013, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoid Tumor; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Cisplatin; Digestive System Neoplasms; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Palliative Care; Retrospective Studies; Sex Factors; Survival Rate; Young Adult

2013
A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation.
    British journal of cancer, 2007, Jul-16, Volume: 97, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Digestive System Neoplasms; Female; Humans; Male; Maximum Tolerated Dose; Micelles; Middle Aged; Nanoparticles; Paclitaxel; Tomography, X-Ray Computed

2007
Intestinal permeability in patients with chemotherapy-induced stomatitis.
    Journal of cancer research and clinical oncology, 2001, Volume: 127, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Digestive System Neoplasms; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Gemcitabine; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Intestinal Absorption; Intestinal Mucosa; Lactulose; Leucovorin; Male; Mannitol; Middle Aged; Paclitaxel; Permeability; Stomatitis; Tegafur; Treatment Outcome; Xylose

2001